Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Innoviva (INVA) Gains from Sales and Divestitures (2016 - 2024)

Historic Gains from Sales and Divestitures for Innoviva (INVA) over the last 16 years, with Q4 2024 value amounting to $241000.0.

  • Innoviva's Gains from Sales and Divestitures fell 1514.08% to $241000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $241000.0, marking a year-over-year decrease of 1514.08%. This contributed to the annual value of $241000.0 for FY2024, which is 1514.08% down from last year.
  • Innoviva's Gains from Sales and Divestitures amounted to $241000.0 in Q4 2024, which was down 1514.08% from $284000.0 recorded in Q4 2023.
  • In the past 5 years, Innoviva's Gains from Sales and Divestitures ranged from a high of $284000.0 in Q4 2023 and a low of $86.0 during Q4 2021
  • Its 5-year average for Gains from Sales and Divestitures is $170417.2, with a median of $233000.0 in 2022.
  • In the last 5 years, Innoviva's Gains from Sales and Divestitures plummeted by 9990.85% in 2021 and then skyrocketed by 27083023.26% in 2022.
  • Innoviva's Gains from Sales and Divestitures (Quarter) stood at $94000.0 in 2020, then crashed by 99.91% to $86.0 in 2021, then soared by 270830.23% to $233000.0 in 2022, then increased by 21.89% to $284000.0 in 2023, then fell by 15.14% to $241000.0 in 2024.
  • Its last three reported values are $241000.0 in Q4 2024, $284000.0 for Q4 2023, and $233000.0 during Q4 2022.